Iovance Biotherapeutics, Inc.
(IOVA - NASDAQ)
8,79 USD
📋 Profilo Aziendale

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions.

|